Arsanis To Present At The Jefferies 2016 Healthcare Conference

WALTHAM, Mass. & VIENNA--(BUSINESS WIRE)--Arsanis, Inc., a clinical-stage biopharmaceutical company developing targeted monoclonal antibodies (mAbs) for pre-emptive and post-infection treatment of serious infectious diseases, today announced that its chief executive officer, René Russo, PharmD, BCPS, will present a company overview at the Jefferies 2016 Healthcare Conference in New York City.

The presentation will take place on Tuesday, June 7, 2016, at 11:00 a.m. EDT.